Gengos Andrew's Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Jun 16, 2025
- Accession no.
- 0001562180-25-004866
- Filed
- Jun 16, 2025
- Trade date
- Jun 13-16, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $57.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gengos AndrewCIK 0001563623 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Common Stock | PPurchaseAcquired | +5,000 | $3.75 | +$18,750 | 5,000 | Direct | |
| Jun 13, 2025 | Common Stock | PPurchaseAcquired | +5,000 | $3.72 | +$18,600 | 10,000 | Direct | |
| Jun 16, 2025 | Common Stock | PPurchaseAcquired | +5,000 | $3.95 | +$19,750 | 15,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.